Mike is a seasoned leader with more than 20 years of experience leading numerous organizations across Medtronic. Mike began his Medtronic career in the field, representing and then leading U.S. Coronary, Peripheral, and broader Cardiovascular Group sales teams in Cardiac rhythm therapies before becoming a general manager.
Mike oversees a comprehensive, market-leading surgical portfolio of products as the recently appointed Executive Vice President and President of the newly combined Surgical Operating Unit; bringing together a legacy of surgical devices and the new robotic-assisted surgery technology to redefine the future of surgery. Most recently, Mike oversaw the Surgical Robotics business where he readied the organization for growth and scale to bring the benefits of robotic-assisted surgery through the recently commercially available Hugo™ RAS system with Touch Surgery™ Enterprise to patients around the world.
Previously, Mike also led the Tachycardia, Bradycardia, and Infection Control teams where he spearheaded initiatives to bring implantable products to market — from innovation through launch to market success. Mike spent four years as president of the Cardiac Rhythm Management Operating Unit. In this role, he led the adoption of the Micra™ transcatheter pacing system, the TYRX™ franchise, and the company’s successful expansion of its business in China.
A leader who is passionate about empowering teams and individuals to achieve their full potential, Mike has been recognized with numerous awards at Medtronic, including the President's Club, Star of Excellence, and Wallin Leadership programs. In 2018, he received a Medtronic Global Inclusion, Diversity, and Engagement (GIDE) award, recognizing his efforts to actively champion strong employee engagement programs, an inclusive work environment, and contributions from different perspectives.
Mike held roles at pharmaceutical and medical device companies prior to joining Medtronic in 2000. He received his bachelor’s degree from Boston College.